Autologous tumor cell killing activity of tumor-associated lymphocytes in patients with head and neck carcinomas

A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 Alone

1987 • 2,769 citations

Use of Tumor-Infiltrating Lymphocytes and Interleukin-2 in the Immunotherapy of Patients with Metastatic Melanoma

1988 • 2,196 citations

Interleukin 2 activation of cytotoxic T-lymphocytes infiltrating into human metastatic melanomas.

1986 • 259 citations

In Vivo Distribution of Adoptively Transferred Indium- 111- Labeled Tumor Infiltrating Lymphocytes and Peripheral Blood Lymphocytes in Patients With Metastatic Melanoma

1989 • 184 citations

Functional analysis of mononuclear cells infiltrating into tumors: lysis of autologous human tumor cells by cultured infiltrating lymphocytes.

1987 • 173 citations

Expression of HLA-A,B,C antigens on primary and metastatic tumor cell populations of human carcinomas.

1991 • 160 citations

Immunohistochemical correlates of response to recombinant interleukin-2-based immunotherapy in humans.

1989 • 134 citations

The glioblastoma‐derived T‐cell suppressor factor/transforming growth factor beta₂ inhibits the generation of lymphokineactivated killer (LAK) cells

1988 • 131 citations

Long-term interleukin 2-dependent growth and cytotoxic activity of tumor-infiltrating lymphocytes from human squamous cell carcinomas of the head and neck.

1987 • 129 citations

Continuous interleukin-2 and tumor-infiltrating lymphocytes as treatment of advanced melanoma. A national biotherapy study group trial

1991 • 119 citations

Clinical results and characterization of tumor-infiltrating lymphocytes with or without recombinant interleukin 2 in human metastatic renal cell carcinoma.

1991 • 103 citations

Cytolytic antitumor effector cells in long-term cultures of human tumor-infiltrating lymphocytes in recombinant interleukin 2

1988 • 72 citations

Lymphocytes infiltrating human ovarian tumors: synergy between tumor necrosis factor alpha and interleukin 2 in the generation of CD8+ effectors from tumor-infiltrating lymphocytes.

1989 • 59 citations

Phase I clinical trial of interleukin 2 and alpha-interferon: toxicity and immunologic effects.

1989 • 57 citations

A phase I study of recombinant interleukin 2 plus recombinant beta-interferon.

1988 • 54 citations

Characterization of human autotumor-reactive T-cell clones obtained from tumor-infiltrating lymphocytes in liver metastasis of gastric carcinoma.

1991 • 54 citations

Tumor-infiltrating lymphocytes from human colon carcinomas

1990 • 46 citations

A phase-II study of low-dose cyclophosphamide and recombinant human interleukin-2 in metastatic renal cell carcinoma and malignant melanoma

1989 • 45 citations

Pilot Study of Interleukin-2 and Lymphokine-Activated Killer Cells Combined With Immunomodulatory Doses of Chemotherapy and Sequenced With Interferon Alfa-2a in Patients With Metastatic Melanoma and Renal Cell Carcinoma

1992 • 36 citations

Lymphokine production by human melanoma tumor-infiltrating lymphocytes

1992 • 18 citations

Treatment with tumour infiltrating lymphocytes and interleukin-2 in patients with metastatic melanoma: A pilot study

1992 • 12 citations

The Treatment of Patients with Melanoma Using Interleukin-2, Interleukin-4 and Tumor Infiltrating Lymphocytes. University of Pittsburgh

1992 • 7 citations